QWQianwen Wang

Qianwen Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qianwen Wang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Jiawen Yin

    Department of Neurology, Institute of Geriatric Medicine, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, China

    1 shared publication
  • Li Wang

    Department of Neurology, The Affiliated Hospital of Northwest University, Xi’an No.3 Hospital, Xi’an, China

    1 shared publication
  • Lingbing Meng

    Graduate School, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 9 Dongdansantiao, Dongcheng District, Beijing 100730, China

    1 shared publication
  • Tao Gong

    Neurology Department, Beijing Hospital,National Center for Gerontology;National Clinical Research Center for Gerontology;The Key Laboratory of Geriatrics of NHC;Institute of Geriatric Medicine,Chinese Academy of Medical Sciences, Beijing, China

    1 shared publication
  • Yuhui Chen

    Department of Neurology, Institute of Geriatric Medicine, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, China

    1 shared publication

Latest Publications

  • Open Access

    A Novel Perspective on Ischemic Stroke: A Review of Exosome and Noncoding RNA Studies

    by Qianwen Wang, Yuhui Chen, Lingbing Meng, Jiawen Yin, Li Wang, Tao Gong

    Ischemic stroke is a life-threatening condition that also frequently results in long-term disability. Currently, intravenous thrombolysis with tissue plasminogen activator and mechanical thrombectomy is the most popular treatment. However, the narrow time window and related complications limit the treatment benefits. Exosomes have recently emerged as ideal therapeutic candidates for ischemic stroke with the ability to pass through the blood_brain barrier and mediate intercellular communication, in addition, exosomes and their contents can be bioengineered to implement targeted delivery. In the last two decades, exosomes and exosomal noncoding RNAs have been found to be involved in the pathophysiological progression of ischemic stroke, including atherosclerosis, apoptosis, inflammation, oxidative stress, and neurovascular remodeling. In this review, we describe the latest progress regarding the role of exosomal long noncoding RNAs and circular RNAs in the occurrence, progression, and recovery of ischemic stroke. Exploration of exosomal noncoding RNAs and their correlated effects in ischemic stroke may facilitate accurate diagnosis, and they may serve as new therapeutic targets for the disease.